Cash report sees no positive effects of the…

/peterschreiber.media, stock.adobe.com Berlin – Despite the measures of the Statutory Health Insurance Financial Stabilization Act (GKV-FinStG), spending on patented drugs is apparently continuing to rise. This is shown by the AMNOG report from DAK-Gesundheit, which